Related Experiment Videos
[Morpho-functional study of peritoneum in peritoneal dialysis]
S V Bertoli1, L Buzzi, D Ciurlino
1U.O. di Nefrologia e Dialisi, Policlinico MultiMedica, Sesto San Giovanni (MI), Italy. silvio.bertoli@multimedica.it
Summary
Peritoneal dialysis (PD) duration impacts mesothelial cells, while glucose load affects the submesothelial layer. Submesothelial sclerosis is not always present and may not cause PD discontinuation.
Area of Science:
- Nephrology
- Histopathology
- Clinical Research
Background:
- Peritoneal dialysis (PD) can negatively affect the peritoneal membrane's (PM) structure and function.
- Understanding the interplay between dialysis parameters, histological changes, and functional outcomes in PD patients is crucial.
Purpose of the Study:
- To investigate the relationships among dialytic, histological, and functional parameters in patients undergoing peritoneal dialysis.
- To identify specific factors contributing to peritoneal membrane damage during PD therapy.
Main Methods:
- Peritoneal biopsy (PB) was performed on 31 PD patients during catheter removal.
- Peritoneal membrane (PM) transport was assessed using the peritoneal equilibration test (PET).
- Histological and immunohistochemical analyses were conducted on peritoneal tissue samples.
Main Results:
- Longer PD treatment duration correlated with mesothelial impairment.
- Higher daily glucose loads were associated with submesothelial sclerosis (SS) and subendothelial vascular membrane (SVM) impairment.
- High transporters showed increased SS thickness and higher glucose loads compared to medium-high transporters.
- Mesothelial loss was linked to SS and vascular alterations, which were interrelated and independent of inflammatory infiltrate.
Conclusions:
- PD duration appears to be a primary factor in mesothelial cell damage.
- Glucose load significantly impacts the submesothelial layer.
- Submesothelial sclerosis (SS) is not a universal finding in PD patients and may not be the sole reason for treatment cessation.